Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance

This publication has 42 references indexed in Scilit:

• Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
  BMC Cancer, 2013
• Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation
  Breast Cancer Research, 2013
• Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
  Proceedings of the National Academy of Sciences, 2011
• The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
  Proceedings of the National Academy of Sciences, 2011
• Estradiol-Induced Regression in T47D:A18/PKCα Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix
  Molecular Cancer Research, 2009
• Gene-Expression Signatures in Breast Cancer
  New England Journal of Medicine, 2009
• The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling
  Endocrine-Related Cancer, 2005
• Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth
  Breast Cancer Research and Treatment, 2005
• Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER+ breast cancer cells
  Apoptosis, 2005
• Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer
  Oncogene, 2000